RAFFA WEALTH MANAGEMENT, LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.6K | Buy |
25
+2
| +9% | +$1.36K | ﹤0.01% | 336 |
|
|
2026
Q1 | $17.8K | Buy |
23
+1
| +5% | +$766 | ﹤0.01% | 290 |
|
|
2025
Q4 | $17K | Hold |
22
| – | – | ﹤0.01% | 291 |
|
|
2025
Q3 | $12.4K | Buy |
22
+4
| +22% | +$2.26K | ﹤0.01% | 325 |
|
|
2025
Q2 | $9.45K | Sell |
18
-5
| -22% | -$2.79K | ﹤0.01% | 389 |
|
|
2025
Q1 | $14.6K | Hold |
23
| – | – | ﹤0.01% | 259 |
|
|
2024
Q4 | $16.4K | Buy |
23
+5
| +28% | +$4.2K | ﹤0.01% | 251 |
|
|
2024
Q3 | $18.9K | Hold |
18
| – | – | ﹤0.01% | 230 |
|
|
2024
Q2 | $18.9K | Hold |
18
| – | – | 0.01% | 334 |
|
|
2024
Q1 | $17.3K | Hold |
18
| – | – | 0.01% | 335 |
|
|
2023
Q4 | $15.8K | Hold |
18
| – | – | ﹤0.01% | 230 |
|
|
2023
Q3 | $14.8K | Hold |
18
| – | – | 0.01% | 224 |
|
|
2023
Q2 | $12.9K | Hold |
18
| – | – | ﹤0.01% | 245 |
|
|
2023
Q1 | $14.8K | Hold |
18
| – | – | 0.01% | 242 |
|
|
2022
Q4 | $13K | Hold |
18
| – | – | 0.01% | 250 |
|
|
2022
Q3 | $12.4K | Sell |
18
-1
| -5% | -$629 | 0.01% | 250 |
|
|
2022
Q2 | $11.2K | Hold |
19
| – | – | 0.01% | 274 |
|
|
2022
Q1 | $13.3K | Buy |
19
+1
| +6% | +$633 | ﹤0.01% | 260 |
|
|
2021
Q4 | $11.4K | Hold |
18
| – | – | ﹤0.01% | 283 |
|
|
2021
Q3 | $10.9K | Hold |
18
| – | – | ﹤0.01% | 252 |
|
|
2021
Q2 | $10.1K | Buy |
18
+1
| +6% | +$507 | ﹤0.01% | 264 |
|
|
2021
Q1 | $8.04K | Buy |
17
+1
| +6% | +$487 | ﹤0.01% | 310 |
|
|
2020
Q4 | $7.73K | Hold |
16
| – | – | ﹤0.01% | 285 |
|
|
2020
Q3 | $8.96K | Hold |
16
| – | – | ﹤0.01% | 250 |
|
|
2020
Q2 | $9.98K | Buy |
16
+3
| +23% | +$1.7K | ﹤0.01% | 229 |
|
|
2020
Q1 | $6.35K | Buy |
13
+7
| +117% | +$2.89K | ﹤0.01% | 246 |
|
|
2019
Q4 | $2.25K | Hold |
6
| – | – | ﹤0.01% | 378 |
|
|
2019
Q3 | $1.66K | Buy |
+6
| New | +$1.77K | ﹤0.01% | 433 |
|
|
2019
Q2 | – | Sell |
-6
| Closed | -$2.46K | – | 1244 |
|
|
2019
Q1 | $2.46K | Hold |
6
| – | – | ﹤0.01% | 322 |
|
|
2018
Q4 | $2.24K | Hold |
6
| – | – | ﹤0.01% | 336 |
|
|
2018
Q3 | $2.42K | Hold |
6
| – | – | ﹤0.01% | 356 |
|
|
2018
Q2 | $2.07K | Sell |
6
-12
| -67% | -$3.75K | ﹤0.01% | 361 |
|
|
2018
Q1 | $6.2K | Buy |
18
+6
| +50% | +$2.09K | ﹤0.01% | 228 |
|
|
2017
Q4 | $4.51K | Hold |
12
| – | – | ﹤0.01% | 221 |
|
|
2017
Q3 | $5.37K | Hold |
12
| – | – | ﹤0.01% | 230 |
|
|
2017
Q2 | $5.89K | Hold |
12
| – | – | ﹤0.01% | 224 |
|
|
2017
Q1 | $4.65K | Hold |
12
| – | – | ﹤0.01% | 218 |
|
|
2016
Q4 | $4.41K | Hold |
12
| – | – | ﹤0.01% | 229 |
|
|
2016
Q3 | $4.82K | Hold |
12
| – | – | ﹤0.01% | 224 |
|
|
2016
Q2 | $4.19K | Hold |
12
| – | – | ﹤0.01% | 224 |
|
|
2016
Q1 | $4.33K | Hold |
12
| – | – | ﹤0.01% | 226 |
|
|
2015
Q4 | $6.51K | Sell |
12
-3
| -20% | -$1.63K | ﹤0.01% | 196 |
|
|
2015
Q3 | $6.98K | Hold |
15
| – | – | ﹤0.01% | 195 |
|
|
2015
Q2 | $7.65K | Buy |
15
+3
| +25% | +$1.46K | ﹤0.01% | 184 |
|
|
2015
Q1 | $5.42K | Hold |
12
| – | – | ﹤0.01% | 189 |
|
|
2014
Q4 | $4.92K | Hold |
12
| – | – | ﹤0.01% | 203 |
|
|
2014
Q3 | $4.33K | Hold |
12
| – | – | ﹤0.01% | 214 |
|
|
2014
Q2 | $3.39K | Hold |
12
| – | – | ﹤0.01% | 201 |
|
|
2014
Q1 | $3.6K | Hold |
12
| – | – | ﹤0.01% | 195 |
|
|
2013
Q4 | $4.92K | Buy |
+12
| New | +$3.45K | ﹤0.01% | 203 |
|
Other funds holding REGN
GA
VF
WCM
AIP
RAFFA WEALTH MANAGEMENT, LLC's REGN Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC increased its Regeneron Pharmaceuticals (REGN) stake by 8.7% in Q2 2026, buying an estimated $1.36K and bringing the position to 25 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #336.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in REGN in Q4 2013 and has held it in 50 quarters since. The position peaked at $18.9K in Q3 2024. 374 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 25 shares of Regeneron Pharmaceuticals worth $15.6K as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC bought 2 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
- Regeneron Pharmaceuticals made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #336 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 50 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's Regeneron Pharmaceuticals position peaked at $18.9K in Q3 2024.
- 374 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.